These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12239212)

  • 1. Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.
    Lee TH; Lwu S; Kim J; Pelletier J
    J Biol Chem; 2002 Nov; 277(47):44826-37. PubMed ID: 12239212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
    Madden SL; Cook DM; Rauscher FJ
    Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells.
    Gurates B; Sebastian S; Yang S; Zhou J; Tamura M; Fang Z; Suzuki T; Sasano H; Bulun SE
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4369-77. PubMed ID: 12213901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation.
    Kim J; Prawitt D; Bardeesy N; Torban E; Vicaner C; Goodyer P; Zabel B; Pelletier J
    Mol Cell Biol; 1999 Mar; 19(3):2289-99. PubMed ID: 10022915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
    Hamilton TB; Barilla KC; Romaniuk PJ
    Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
    Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J
    Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.
    Johnstone RW; See RH; Sells SF; Wang J; Muthukkumar S; Englert C; Haber DA; Licht JD; Sugrue SP; Roberts T; Rangnekar VM; Shi Y
    Mol Cell Biol; 1996 Dec; 16(12):6945-56. PubMed ID: 8943350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b).
    Wagner KD; Wagner N; Schley G; Theres H; Scholz H
    Gene; 2003 Feb; 305(2):217-23. PubMed ID: 12609742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1.
    Wang W; Lee SB; Palmer R; Ellisen LW; Haber DA
    J Biol Chem; 2001 May; 276(20):16810-6. PubMed ID: 11278547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1.
    Matsuzawa-Watanabe Y; Inoue J; Semba K
    Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
    Song KH; Park YY; Park KC; Hong CY; Park JH; Shong M; Lee K; Choi HS
    Mol Endocrinol; 2004 Aug; 18(8):1929-40. PubMed ID: 15155786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.